Skip to main content

American Well Corp (AMWL)

Computer Software and Services Information Technology
Stock AI

Financial Metrics

Price to Earnings-2.75x
Revenue Growth (1Y)-29.12%
Debt to Equity0.013x

Strengths

Stock Chart

Valuation

American Well Corp is overvalued

News

All
Press Releases
News
Filings
Amwell makes grant to new employees under inducement plan
August 07, 2026Amwell makes grant to new employees under inducement plan
Amwell® Announces Results for the Second Quarter 2026
August 04, 2026Amwell® Announces Results for the Second Quarter 2026
10-Q Quarterly Report for 2026 Q2
August 04, 202610-Q Quarterly Report for 2026 Q2
Amwell® to report second quarter 2026 operating results
July 24, 2026Amwell® to report second quarter 2026 operating results
Amazon's top health exec is stepping down, will be replaced by Amwell co-founder
May 27, 2026Amazon's top health exec is stepping down, will be replaced by Amwell co-founder
Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
May 18, 2026Nature Human Behaviour study finds SilverCloud® by Amwell® reduced prevalence of mental disorders over two years at scale
Amwell® to Participate in Upcoming Investor Conference
May 11, 2026Amwell® to Participate in Upcoming Investor Conference
Amwell® Announces Results for First Quarter 2026
May 05, 2026Amwell® Announces Results for First Quarter 2026
10-Q Quarterly Report for 2026 Q1
May 05, 202610-Q Quarterly Report for 2026 Q1
Amwell® to report first quarter 2026 operating results
April 20, 2026Amwell® to report first quarter 2026 operating results
Amwell® to Participate in Upcoming Investor Conference
February 24, 2026Amwell® to Participate in Upcoming Investor Conference
Amwell makes grant to new employee under inducement plan
February 18, 2026Amwell makes grant to new employee under inducement plan
Amwell® Announces Results for Fourth Quarter and Full Year 2025
February 12, 2026Amwell® Announces Results for Fourth Quarter and Full Year 2025
10-K Annual Report for 2025 FY
February 12, 202610-K Annual Report for 2025 FY
Amwell® to report fourth quarter and full year 2025 operating results
February 05, 2026Amwell® to report fourth quarter and full year 2025 operating results
Amwell® Announces Results for Third Quarter 2025
November 04, 2025Amwell® Announces Results for Third Quarter 2025
10-Q Quarterly Report for 2025 Q3
November 04, 202510-Q Quarterly Report for 2025 Q3
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
October 27, 2025Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
Amwell makes grant to new employees under inducement plan
August 08, 2025Amwell makes grant to new employees under inducement plan
Amwell® Announces Results for Second Quarter 2025
August 05, 2025Amwell® Announces Results for Second Quarter 2025
Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
August 05, 2025Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”)
10-Q Quarterly Report for 2025 Q2
August 05, 202510-Q Quarterly Report for 2025 Q2
Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
July 22, 2025Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences
Amwell® Announces Results for First Quarter 2025
May 01, 2025Amwell® Announces Results for First Quarter 2025
10-Q Quarterly Report for 2025 Q1
May 01, 202510-Q Quarterly Report for 2025 Q1
Amwell® to participate in upcoming investor conferences
April 24, 2025Amwell® to participate in upcoming investor conferences
Amwell® to report first quarter 2025 operating results
April 17, 2025Amwell® to report first quarter 2025 operating results
Amwell makes inducement grant
March 03, 2025Amwell makes inducement grant
Amwell announces innovation leader as chief product and technology officer
March 03, 2025Amwell announces innovation leader as chief product and technology officer
Amwell® makes grants to new employees under inducement plan
February 21, 2025Amwell® makes grants to new employees under inducement plan
Amwell® to participate in upcoming investor conference
February 19, 2025Amwell® to participate in upcoming investor conference
Amwell® Announces Results for Fourth Quarter and Full Year 2024
February 12, 2025Amwell® Announces Results for Fourth Quarter and Full Year 2024
10-K Annual Report for 2024 FY
February 12, 202510-K Annual Report for 2024 FY
Amwell® to report fourth quarter and full year 2024 operating results
January 29, 2025Amwell® to report fourth quarter and full year 2024 operating results
Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
January 15, 2025Amwell® adds Vida to its clinical programs portfolio expanding access to obesity and diabetes care
Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
January 09, 2025Amwell® divests virtual psychiatric care business to Avel eCare in all-cash transaction
Amwell CFO Mark Hirschhorn Expands Leadership Role
December 18, 2024Amwell CFO Mark Hirschhorn Expands Leadership Role
Amwell Makes Grants to New Employees Under Inducement Plan
November 04, 2024Amwell Makes Grants to New Employees Under Inducement Plan
10-Q Quarterly Report for 2024 Q3
October 30, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
July 31, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 01, 202410-Q Quarterly Report for 2024 Q1
10-K/A Annual Report for 2023 FY
March 01, 202410-K/A Annual Report for 2023 FY
10-K Annual Report for 2023 FY
February 15, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 01, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 02, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 03, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
February 23, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 08, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 05, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 10, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
February 28, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 12, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

American Well Corp, commonly known as Amwell, operates as a leading enterprise platform and software company that digitally empowers hybrid healthcare delivery. Established in 2006, Amwell is recognized for pioneering virtual healthcare and extending its services beyond simple telehealth offerings, integrating in-person, virtual, and automated care capabilities. The organization is committed to enabling healthcare providers, payers, and innovators to fulfill their digital healthcare ambitions, forging a coordinated experience across diverse modalities of care.

At its core, Amwell provides a comprehensive enterprise platform and Software as a Service (SaaS) solutions, designed to equip clients with the essential technology and services required to successfully develop and deploy digital care programs tailored to their operational, clinical, financial, and strategic objectives. This flexibility allows clients to brand and personalize the digital healthcare experience for their users.

As of the end of 2023, Amwell has successfully facilitated over 27.2 million virtual care visits for its clients, servicing more than 50 health plans that cover over 100 million lives, along with major health systems across the United States.

B. Business Model and Service Offerings

Hybrid Care Model

Amwell's hybrid care model offers solutions for both healthcare systems and plans. Its enterprise platform supports a diverse range of use cases, which encompass urgent care, primary care, chronic disease management, behavioral health, and specialty follow-up care. Health systems are empowered to utilize the platform for provider-to-provider consultations alongside patient care modalities.

Amwell's products integrate seamlessly into health systems’ workflows, enabling virtual care from within existing infrastructure, such as Electronic Health Records (EHR) systems, thereby reducing administrative burdens for providers. The solution includes synchronization with clinical practices and enhancing in-person care with integrated digital tools.

Carepoint Devices

The company has developed the CarepointTM suite of devices, which can convert existing hardware, such as televisions and tablets, into digital access points for remote care. Carepoint also includes specialized carts and peripherals that facilitate patient monitoring and virtual nursing in various settings, from hospitals to community locations.

Converge™ Platform

The flagship Converge™ platform represents the latest iteration of Amwell's enterprise technology, designed to be highly reliable, flexible, and interoperable. As a FHIR-native system, it ensures compatibility with various healthcare data systems and promotes a holistic approach to managing care experiences across all patient interactions.

The platform aggregates data from various care modalities, providing real-time insights that improve patient management and enable more effective clinical decision-making.

Clinical Services and Workforce Augmentation

To enhance its core technological solutions, Amwell operates the Amwell Medical Group® (AMG), which consists of a nationwide network of multidisciplinary providers. This network offers comprehensive medical staffing solutions, including behavioral health services and specialty consultations, supported by a rigorous accreditation process.

In addition, Amwell offers value-added services to assist clients in implementing solutions, streamlining workflows, and promoting patient and provider engagement.

C. Market Opportunity

The U.S. digital care market is rapidly growing, with Amwell estimating the combined addressable market for associated segments to be substantial — approximately $94 billion. Within this segment, the addressable market specifically for hybrid care platforms like Converge is expected to grow from $31 billion to approximately $50 billion over four years.

Amwell's clientele includes over 290 million lives enrolled in identified health plans and approximately 930 health systems exploiting Amwell's capabilities for patient care.

D. Competitive Landscape

Within the digital healthcare sector, Amwell faces competition from several fronts:

  • Traditional platform telehealth providers (e.g., Teladoc, Caregility)
  • Consumer-oriented telehealth firms (e.g., MDLive)
  • Technology giants making inroads into healthcare (e.g., Microsoft, Amazon)
  • EHR providers, digital engagement platforms, and dedicated virtual nursing offerings.

Despite the competition, Amwell's position is strengthened by its focus on partnership and integration, promoting its platform’s open architecture that allows for collaboration with both healthcare providers and technology innovators.

E. Technological Capabilities

Security and Reliability

Amwell’s technology infrastructure emphasizes security, leveraging advanced encryption methodologies and a multi-tiered security architecture. The enterprise platform maintains compliance with industry regulations, ensuring patient information is safeguarded.

Data Analytics and Integration

The platform includes analytics capabilities that inform healthcare stakeholders about operational performance and patient care efficiency. It also supports integration with various systems, streamlining clinical management and enhancing overall care delivery.

F. Future Strategies

Going forward, Amwell aims to increase client adoption through several key strategies:

  1. Expanding service populations: Encouraging health plans and systems to broaden their service offerings to cover more members over time.
  2. Driving usage growth: Through targeted engagement campaigns for both patients and providers.
  3. New solutions introduction: Developing and promoting additional service lines for digital care delivery to enhance client offerings and revenue potential.
  4. Carepoint suite expansion: Encouraging clients to increase the number of Carepoint devices to enhance digital care access.
  5. Adoption of Converge: Focusing on the migration of existing clients onto the latest version of the enterprise platform.

International market expansion and opportunistic acquisitions also represent part of Amwell’s growth trajectory, targeting enhanced global service offerings, particularly in behavioral health through its SilverCloud brand.

Stock Infos

SectorInformation Technology
IndustryComputer Software and Services
CEOIdo Schoenberg

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.